BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Heenan Blaikie, Jean Chretien Team With Millenia Hope In A Crusade Against Malaria


7/11/2006 11:45:23 AM

MONTREAL and WILMINGTON, Del., July 11 /PRNewswire-FirstCall/ -- Millenia Hope Inc., a Biopharma , announced today that the prestigious Canadian Law Firm, Heenan Blaikie, with the support of one of its senior partners, the Rt. Honorable Jean Chretien, former Prime Minister of Canada for 10 years and a great advocate for the people of Africa, has pledged its resources to help alleviate the human suffering and devastation caused by malaria in Africa. Millenia Hope, a Montreal, Canada based U.S. Biopharma, has dedicated its resources for the past nine years to developing its anti-malarial drug, Malarex/MMH 18.

Heenan Blaikie and Mr. Chretien have committed themselves to fight debilitating infectious diseases in Africa, with an initial focus on malaria. They are appealing to the supporters of this noble cause to join them in fighting these devastating diseases. In an effort to initiate this crusade against malaria, they have chosen to join hands with Millenia Hope Inc. Heenan Blaikie applauds the passion and commitment of Millenia's tenacious efforts to develop a global solution for the Malaria disease. Mr. Jacques Bouchard Jr., spearheading Heenan Blaikie's efforts in this regard, has been instrumental in forging this unique humanitarian alliance between Heenan Blaikie, and Millenia Hope Inc., to fight malaria in Africa.

Leonard Stella, Chairman and CEO of Millenia Hope, stated, "Heenan Blaikie, represented in this effort by Former Prime Minister Chretien, has pledged itself as Canadian goodwill Ambassadors to do their utmost to help Africa. We hope and pray that their fiery passion and our total commitment to alleviate the suffering caused by malaria will be dawn of a new era for the people of Africa."

ABOUT MILLENIA HOPE:

Millenia Hope develops innovative treatments and products that enhance the quality of life, has put in place programs to fight major infectious diseases, and promote healthier lives. Our team is committed to research and development to deliver on global medical needs and to bring hope through healthcare solutions.

ABOUT HEENAN BLAIKIE:

Heenan Blaikie has become one of the leading law firms in Canada. The firm is over 400 lawyers strong and has been involved in commercial transactions and advisory projects all over the world, more specifically in many African countries.

Heenan Blaikie has within its ranks a number of prominent individuals who have made their mark on the international stage, including the Rt. Honorable Jean Chretien, P.C., Q.C., former Prime Minister of Canada, Pierre-Marc Johnson, Former Premier of the Province of Quebec as well as the Honorable Donald J. Johnston, the Former Secretary-General of the OECD.

SAFE HARBOR STATEMENTS:

Certain statements made in the release may contain language describing the plans, goals, strategies, intentions, forecasts, and expectations of Millenia Hope/Millenia Hope Biopharma that may be referred to as "forward-looking statements." Several important factors could cause actual results to differ materially from those in such forward-looking statements and Millenia Hope could encounter unanticipated obstacles and delays in developing products, services and markets.

Millenia Hope Inc.

CONTACT: Mr. Leonard Stella, CEO of Millenia Hope Inc., +1-514-846-5757,+1-514-288-8822, leostella@milleniahope.com



Read at BioSpace.com

   
Malaria

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES